{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:26:40Z","timestamp":1783729600314,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.euroneuro.2011.09.004","type":"journal-article","created":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T22:08:09Z","timestamp":1317506889000},"page":"374-378","source":"Crossref","is-referenced-by-count":34,"title":["The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating"],"prefix":"10.1016","volume":"22","author":[{"given":"David","family":"Feifel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Shilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle M.","family":"Belcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0306-4530(85)90056-3","article-title":"Vasopressin\u2014oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls","volume":"10","author":"Beckmann","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.euroneuro.2011.09.004_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/7854_2010_61","article-title":"Prepulse inhibition of the startle reflex: a window on the brain in schizophrenia","volume":"4","author":"Braff","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.mp.4002150","article-title":"Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice","volume":"14","author":"Caldwell","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2011.09.004_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00213-010-1815-x","article-title":"Assessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test","volume":"210","author":"Chaviaras","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.euroneuro.2011.09.004_bb0025","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1037\/0735-7044.119.4.1052","article-title":"Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain","volume":"119","author":"Conti","year":"2005","journal-title":"Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0030","first-page":"77","article-title":"On the blood\u2013brain barrier to peptides: effects of immobilization stress on regional blood supply and accumulation of labelled peptides in the rat brain","volume":"26","author":"Dvorska","year":"1992","journal-title":"Endocr. Regul."},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2011.09.004_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0014-2999(98)00513-5","article-title":"Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation","volume":"355","author":"Engstrom","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2011.09.004_bb0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/jcbfm.1985.49","article-title":"Blood\u2013brain barrier and peptides","volume":"5","author":"Ermisch","year":"1985","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"1","key":"10.1016\/j.euroneuro.2011.09.004_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002130050811","article-title":"Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating","volume":"141","author":"Feifel","year":"1999","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.euroneuro.2011.09.004_bb0050","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.biopsych.2010.04.039","article-title":"Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients","volume":"68","author":"Feifel","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1037\/a0022691","article-title":"Clozapine and PD149163 elevate prepulse inhibition In Brown Norway rats","volume":"125","author":"Feifel","year":"2011","journal-title":"Behavioral Neuroscience"},{"issue":"2\u20133","key":"10.1016\/j.euroneuro.2011.09.004_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","article-title":"Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review","volume":"156","author":"Geyer","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2011.09.004_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2007.09.019","article-title":"Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits","volume":"98","author":"Goldman","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0065","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000321035","article-title":"The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder","volume":"18","author":"Harony","year":"2010","journal-title":"Neurosignals"},{"issue":"6","key":"10.1016\/j.euroneuro.2011.09.004_bb0070","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.03.005","article-title":"The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior","volume":"65","author":"Insel","year":"2010","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0075","first-page":"57","article-title":"Modulary effects of oxytocin and carbetocin on stress-induced changes in rat behavior in the open-field","volume":"60","author":"Klenerova","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2011.09.004_bb0080","first-page":"335","article-title":"Oxytocin and carbetocin effects on spontaneous behavior of male rats: modulation by oxytocin receptor antagonists","volume":"30","author":"Klenerova","year":"2009","journal-title":"Neuro Endocrinol. Lett."},{"issue":"10","key":"10.1016\/j.euroneuro.2011.09.004_bb0085","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/sj.npp.1300722","article-title":"Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin","volume":"30","author":"Lee","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.euroneuro.2011.09.004_bb0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00461555","article-title":"Cerebrospinal fluid neurophysins in affective illness and in schizophrenia","volume":"234","author":"Linkowski","year":"1984","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"issue":"1","key":"10.1016\/j.euroneuro.2011.09.004_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10673220903523615","article-title":"The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans","volume":"18","author":"Macdonald","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"issue":"13","key":"10.1016\/j.euroneuro.2011.09.004_bb0100","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1471-0528.2010.02739.x","article-title":"Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial","volume":"117","author":"Page","year":"2010","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1037\/0735-7044.114.2.374","article-title":"Prepulse startle deficit in the brown norway rat: a potential genetic model","volume":"11","author":"Palmer","year":"2000","journal-title":"Behav. Neurosci."},{"issue":"4","key":"10.1016\/j.euroneuro.2011.09.004_bb0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2005.09.025","article-title":"Sensorimotor gating deficits in adults with autism","volume":"61","author":"Perry","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.euroneuro.2011.09.004_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2010.09.014","article-title":"Peripheral oxytocin is associated with reduced symptom severity in schizophrenia","volume":"124","author":"Rubin","year":"2010","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.euroneuro.2011.09.004_bb0120","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2010.12.022","article-title":"Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism","volume":"69","author":"Sala","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2011.09.004_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpsyc.1994.03950020063007","article-title":"Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients","volume":"51","author":"Swerdlow","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2011.09.004_bb0130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.pbb.2007.08.013","article-title":"A novel rat strain with enhanced sensitivity to the effects of dopamine agonists on startle gating","volume":"88","author":"Swerdlow","year":"2008","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11002197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X11002197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:56:37Z","timestamp":1543517797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X11002197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0924977X11002197"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2011.09.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}